期刊文献+

儿童急性髓系白血病基因拷贝数变异的临床研究 被引量:1

Copy Number Variations in Pediatric Acute Myeloid Leukemia
下载PDF
导出
摘要 目的:研究儿童急性髓系白血病(AML)中基因拷贝数变异的发生率及其与临床特征及预后的相关性。方法:回顾性分析130例AML患儿临床资料,包括临床特征、FAB分型及细胞遗传学改变等。收集130例AML患儿和38例健康志愿儿童的骨髓或外周血,常规提取基因组DNA。应用多重连接探针扩增法(MLPA)检测多个基因拷贝数变异的情况。利用SPSS16.0软件进行统计学分析。结果:在130例患儿中,超过10%的拷贝数变异涉及的染色体区段为2p24.3(MYCN)、10q23(PTEN)和13q14(RB1,MIR15A,DLEU);在49例(37.7%)患者中检测到基因探针的扩增和缺失,涉及改变的基因探针个数的中位数为4个。TP53探针发生缺失/扩增的患儿复发率高。各探针发生缺失/扩增对EFS、DFS及OS均无影响。12%的患儿存在基因组异常,用常规染色体核型的方法不能检出。结论:MLPA技术可作为染色体核型检测的补充。TP53拷贝数异常的儿童AML患者易发生复发。 Objective: To evaluate the copy number variations (CNV) of gene in pediatric acute myeloid leukemia (AML) and its correlation with clinical features and prognosis. Methods:The clinical data of 130 children aged 〈 14 years with newly diagnosed AML from May 2006 to March 2013 were analyzed restrospectively. The CNV were analyzed by multiplex ligation-dependent probe amplification (MLPA). Thirty-eight normal children were selected in control group. All the data were statistically analyzed using SPSS16.0 software. Results: gene CNV of 2p24. 3 ( MYCN), 10q23 (PTEN) and 13q14 ( RB1, MIR15A, DLEU) were detected in more than 10% of the patients. CNV were detected in 49 cases(37.7% ). The median loss and gain CNV frequencies per sample were 4. The CNV of TP53 correlated significantly with relapse. The loss ond gain CNV have no influence to EFS, DSF and OS. CNV were detected in the twelve percent of patients, but they were not detected with routine karyotype method. Conclusion:The MLPA technique combined with karyotyping makes a substantial increase in the diagnostic rate. Patients with TP53 alterations have significantly higher relapse rate.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2015年第2期295-299,共5页 Journal of Experimental Hematology
基金 国家重大科学研究计划(2012CB966603) 国家自然科学基金(81200396) 天津市科技支撑计划(12zcdzsy18100)
关键词 儿童 急性髓系白血病 拷贝数变异 child acute myeloid leukemia copy number variation
  • 相关文献

参考文献18

  • 1Ran R, Brown P. Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leu- kaemia entity. Hematol Oncol, 2009 ;27(4) :171 2 181.
  • 2Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neo- plasms and acute leukemia : rationale and important changes. Blood, 2009;114(5) :937 -951.
  • 3Mrozek K, Marcucci G, Paschka P, et al. Clinical relevance of mu- tations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics : are we ready for a prognostically prioritized molecular classification ? Blood, 2007 ; 109 ( 2 ) :431 - 448.
  • 4Wakita S1, Yamaguchi H, Omori I, et al. Mutations of the epigenet- ics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may in- duce FLT3-ITD at relapse in de novo acute myeloid leukemia. Leuke- mia. 2013 Apr;27(5) :1044 - 1052.
  • 5周剑峰,张丽,曾慧敏,王雅琴,衣晓丽,安文彬,常丽贤,邹尧,陈玉梅,竺晓凡.儿童急性髓系白血病DNMT3a基因突变的分析[J].中国实验血液学杂志,2012,20(6):1297-1301. 被引量:3
  • 6张丽,曾慧敏,艾晓非,杨文钰,陈晓娟,郭晔,王书春,刘晓明,阮敏,张家源,刘天峰,邹尧,陈玉梅,竺晓凡.儿童急性髓系白血病NPMl和IDH基因突变的研究[J].中华血液学杂志,2013,34(5):449-452. 被引量:3
  • 7Mullighan CG. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice. Clin Cancer Res, 2011 ;17(3) :396 -400.
  • 8Mullighan CG, Downing JR. Global genomic characterization of acute lymphoblastie leukemia. Semin Hematol, 2009; 46 ( 1 ) :3 - 15.
  • 9Kim KI, Kim TK, Kim IW, et al. Copy number variations in normal karyotype acute myeloid leukaemia and their association with treat- ment response. Basic Clin Pharmacol Toxicol, 2012 ; 111 ( 5 ) : 317 - 324.
  • 10Walter M J, Payton JE, Ries RE, et al. Acquired copy number alter- ations in adult acute myeloid leukemia genomes. Proc Natl Acad Sci USA, 2009;106(31 ) :12950 - 12955.

二级参考文献34

  • 1颜灵芝,陈苏宁,梁建英,冯宇峰,岑建农,何军,常伟荣,朱子玲,潘金兰,吴亚芳,薛永权,吴德沛.急性髓系白血病患者NPM1基因突变分析[J].中华血液学杂志,2007,28(5):289-293. 被引量:17
  • 2Frohling S, Scholl C, GiUiland DG, et al. Genetics of myeloid malignancies : pathogenetic and clinical implications. J Clin Oncol, 2005 ; 23 (26) : 6285 - 6295.
  • 3Pui CH, Carroll WL, Meshinchi S, et al. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clinical Oncol, 2011 ; 29(5) : 551 -565.
  • 4Ley TJ, Ding L, Walter MJ, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med, 2010; 363 (25) : 2424 -2433.
  • 5Ho PA, Kntny MA, ALonzo TA, et al. Leukemic Mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group. Pediatr Blood Cancer, 2011 ; 57(5) : 204 -209.
  • 6Shiba N, Taki T, Park MJ, et al. DNM'I3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia. Br J Haematol, 2012; 156 (3) : 413 -414.
  • 7Renneville A, Roumier C, Biggio V, et al. Cooperating genemutations in acute myeloid leukemia: a review of the literature. Leukemia, 2008; 22(5) : 915 -931.
  • 8Mardis ER, Ding L, Dooling DJ, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med, 2009; 361(11) : 1058 -1066.
  • 9Ward PS, Patel J, Wise DR, et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglu- tarate to 2- hydroxyglutarate. Cancer Cell, 2010 ; 17 ( 3 ) : 225 - 234.
  • 10Hou HA, Kuo YY, Liu CY, et al. DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical impfications. Blood, 2012; 119(2) :559 -568.

共引文献3

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部